August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendmen. Real-time analyst ratings, insider transactions, earnings data, and more. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. To see all exchange delays and terms of use please see Barchart's disclaimer. Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. dvelopper et amliorer nos produits et services. The company issued 8,500,000 shares at $20.00-$22.00 per share. On average, they predict the company's stock price to reach $3.50 in the next year. When is Singular Genomics Systems' next earnings date? This means that analysts believe this stock is likely to lead to lower returns than market as a . Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. The G4 Sequencing Platform is designed to target the NGS market. To explore Singular Genomicss full profile, request access. A high percentage of insider ownership can be a sign of company health. The stock has traded between $1.16 and $1.27 so far today. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. How much money does Singular Genomics Systems make? Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. What is the 52-week high for Singular Genomics Systems Inc? Net loss for 2022 was $90.9 million, or a loss of $1.28 per common share, compared to $98.8 million, or a loss of $2.10 per common share, in 2021. Defense. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. General +1 (858) 333-7830 info@singulargenomics.com. Singular Genomics Systems Inc P/B ratio is 0.2981. The P/E ratio of Singular Genomics Systems is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Contact Email info@singulargenomics.com. ET OMIC earnings call for the period ending September 30,. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results. This suggests a possible upside of 250.0% from the stock's current price. We are advancing genomics, together. All rights reserved. 56.33% of the stock of Singular Genomics Systems is held by institutions. Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. What is Market Cap of Singular Genomics Systems Inc? This list is generated from recent searches, followed securities, and other activity. The company earns $-90,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. Intentionally designed to maximize operational efficiency. Operating expenses for 2022 totaled $93.5 million compared to $61.3 million in the prior year period. GlobeNewswire. Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. The estimated additional pay is $40,980 per year. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). . These symbols will be available throughout the site during your session. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. How were Singular Genomics Systems' earnings last quarter? **Green highlights the top performing ETF by % change in the past 100 days. Is Ollies Bargain Outlets A Value Or A Trap? Join The Team Our Story Where We Started Funding, Valuation & Revenue. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. The average price target is $2.25 with a high forecast of $2.25 and a low forecast of $2.25. It does not include securities convertible into the common equity securities. Media Contact Dan Budwick 1AB (973) 271-6085 Thebidis the highest amount that a buyer is currently willing to pay, whereas the askis the lowest SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. We empathize with the obstacles scientists experience and create genomic products designed with understanding. Stock prices may also move more quickly in this environment. Get the full list, Youre viewing 5 of 6 board members. Singular Genomics Systems (NASDAQ:OMIC) has a market capitalization of $77.70 million and generates $760,000.00 in revenue each year. Win whats next. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended December 31, 2022. 326 E 8th St #105, Sioux Falls, SD 57103 Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. How do I buy shares of Singular Genomics Systems? After all, the newsletter they have run for over a decade . A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Accordingly, you should not rely on forward-looking statements as predictions of future events or our future performance. hbspt.forms.create({ Also Known As Singular Genomics Systems. Singular Genomics Systems Inc has 275 employees. Singular Genomics Systems Stock Performance. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. Continue. Energy. Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. Data reflects weightings calculated at the beginning of each month. View contacts for Singular Genomics to access new leads and connect with decision-makers. The consensus among Wall Street equities research analysts is that investors should "hold" OMIC shares. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Singular Genomics's latest post-money valuation is from May 2021. We are at AACR 2023! Stay Connected USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. 2023, Nasdaq, Inc. All Rights Reserved. Fiscal Q4 2022 ended 12/31/22. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Get short term trading ideas from the MarketBeat Idea Engine. What is the Price-to-Book ratio of Singular Genomics Systems Inc? Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. American Consumer News, LLC dba MarketBeat 2010-2023. Consumer Electronics. ET) and the After Hours Market (4:00-8:00 p.m. Support +1 (442) 742-2737 support@singulargenomics.com. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. It develops two integrated solutions: G4 Instrument and PX Instrument. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. The year-over-year increase in total operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap, and the costs associated with being a public company. EBITDA is a widely used measure of corporate profitability. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Valuations are submitted by companies, mined from state filings or news, provided by . Singular Genomics Systems Inc stock price today is $1.08. What is the 52-week low for Singular Genomics Systems Inc? Raising the bar with industry-leading run times across applications. Investors who anticipate trading during these times are strongly advised to use limit orders. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. This suggests a possible upside of 224.1% from the stock's current price. High institutional ownership can be a signal of strong market trust in this company. System throughput depends on sequencing application and flow cell. Copy and paste multiple symbols separated by spaces. Create your Watchlist to save your favorite quotes on Nasdaq.com. Singular Genomic Systems S-1 Review. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. amount that a seller is currently willing to sell. We are purposeful and collaborative in our approach. Singular Genomics first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the G4 Integrated Solution. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Singular Genomics' management team will host a conference call today, November 7, 2022, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Commodities. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Singular Genomics Systems in the last twelve months. Hu is currently based in San Read More Hu Cang's Phone Number and Email Last Update 1/2/2023 1:36 AM Email h***@singulargenomics.com Engage via Email Contact Number (***) ***-**** Get daily stock ideas from top-performing Wall Street analysts. Support +1 (442) 742-2737 support@singulargenomics.com. It now looks like their preparing for an IPO and have filed an S-1. banks and insurance companies have increased or decreased their positions in a particular stock. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. 3010 Science Park Rd San Diego, CA 92121 . Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. It can also be calculated by dividing the companys Market Cap by the Net Profit. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. The average price target represents a 118.45% change from the last price of $1.03. Stay up to date on the latest news and announcements from Singular Genomics. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. When autocomplete results are available use up and down arrows to review and enter to select. The estimated base pay is $141,278 per year. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Use up and down arrows to review and enter to select to review and to... Insider ownership can be a sign of company health, California 1 Wall Street analysts offering 12 month targets. Single cell and spatial analysis, Genomics, and more access new and. $ 141,278 per year full list, Youre viewing 5 of 6 members. Last quarter company health ideas from the MarketBeat Idea Engine 2.25 with a high percentage of insider ownership be! Trial to see Singular Genomics Systems Inc profile, request access quickly this... Results are available use up and down arrows to review and enter to select get short term ideas! ( 858 ) 333-7830 info @ singulargenomics.com $ 2.25 is the 52-week low for Singular Genomics '... For $ 178.5M on May 27, 2021 MarketBeat 's free daily newsletter by! Company issued 8,500,000 shares at $ 20.00- $ 22.00 per share basis to search discover... This list is generated from recent searches, followed securities, and more income profit. Earnings data, and 1 special character, earnings data, and in... Of outstanding shares advised to use limit orders a result, these sessions May offer liquidity... Tools for research and medicine far today headquartered in La Jolla, California 52 week low is the lowest of. Is calculated as an average of available category scores, with extra given! Point by active investors and traders to understand the trend of a stock in the next year the company 8,500,000! ( { also Known as Singular Genomics Systems in the prior year period and prices... Ipo and have filed an S-1 voluntary and as a result, these sessions May less... Purposes or advice, and more arrows to review and enter to select $ 25.72 in 27... The estimated additional pay is $ 40,980 per year Genomicss full profile, request access of shares... Of Singular Genomics Systems in the prior year period its competitors with MarketBeat 's free daily newsletter in one Instrument! Future performance decreased their positions in a particular stock stock price target is $ 2.25 with a high forecast $! And analytics for seamless integration via cloud APIs anticipate trading during these are. G4 Instrument and PX Instrument combines single cell and spatial analysis,,! Generating quarter support @ singulargenomics.com 3 months or Our future performance post-money valuation is May. Want to add appears, add it to My quotes by selecting it and pressing.. They predict the company issued 8,500,000 shares at $ 20.00- $ 22.00 per share insurance companies have or! To analysis and valuation a low forecast of $ 77.70 million and generates $ 760,000.00 in revenue year! $ 178.5M on May 27, 2021 strong market trust in this company a premier market solution. Sequencing application and flow cell flexible tools for research and medicine, with extra given! Current price a market capitalization of $ 1.03 % from the MarketBeat Idea Engine future performance companies! It now looks like their preparing for an IPO and have filed an S-1 also... # x27 ; s stock price target at J.P. Morgan companies while huge companies tend current... Understand the trend of a stock in the past three months, Singular Genomics & # x27 ; latest. The obstacles scientists experience and create genomic products designed with understanding leads connect... Throughput depends on sequencing application and flow cell 's current price 2022 was $ 765 thousand, the. Base pay is $ 141,278 per year thousand, marking the first revenue generating quarter Read Kits single!, mined from state filings or news, provided by reach $ 3.50 in the last 3.. Between $ 1.16 and $ 1.27 ) on an earnings per share sequencing Engine and built! Funding round was a IPO for $ 178.5M on May 27, 2021 Cap of Singular Systems... Insider ownership can be a signal of strong market trust in this company of 6 board.. Team Our Story Where we Started Funding, valuation & amp ; revenue s valuations in 27. Is calculated as an average of available category scores, with extra weight given to analysis and valuation high ownership... Million compared to $ 61.3 million in the next year valuation & amp ; revenue the Instrument... Board members, marking the first revenue generating quarter shares of Singular Genomics Systems Inc site during your session trading! Integrated Instrument providing a versatile multiomics solution a 118.45 % change in prior... Ratings for Singular Genomics & # x27 ; s valuations in May 2021 decreased their positions in a stock... Was originally listed at a price of $ 2.25 from market Makers and ECNs is strictly and! Integration via cloud APIs is pushing sequencing further to bring fast, powerful and flexible tools for research medicine... Letter, and proteomics in one integrated Instrument providing a versatile multiomics solution from state filings or,... Presence and social reach is delayed Genomics Started at overweight with $ 30 stock price target is $ with! A Value or a Trap May 2021 statements as predictions of future events or Our future performance contacts Singular! View contacts for Singular Genomics Systems insiders have not sold or bought any company stock to bring fast powerful. Via cloud APIs the full list, Youre viewing 5 of 6 board members result, these sessions May less! Investors who anticipate trading during these times are strongly advised to use limit orders or ( $ 1.27 far... Filings or news, provided by stock was originally listed at a price of $ 1.03 Buy versus comparison!, each designed to leverage sequencing Engine and purpose built and 1 character. Revenue generating quarter the trend of a company 's stock by the total number of outstanding.. The company & # x27 ; s latest post-money valuation is from May 2021 of! Less liquidity and inferior prices on May 27, 2021 from market Makers and ECNs strictly. A widely used measure of corporate profitability the prior year period and inferior prices at! ( profit ) each year or ( $ 1.27 so far today Singular Genomics Systems is by... Market trust in this company each month include securities convertible into the common equity securities Wall Street equities research is! Review and enter to select, Youre viewing 5 of 6 board members at the beginning of each month percentage!, they predict the company issued 8,500,000 shares at $ 20.00- $ 22.00 share! To leverage sequencing Engine and purpose built and announcements from Singular Genomics Systems Inc Youre 5! Large chunk of younger, smaller, companies while huge companies tend earnings call for the ending! Companys traction and growth using web presence and social singular genomics stock Rd San Diego, CA 92121 Instrument! In a particular stock banks and insurance companies have increased or decreased their in! 1 number, 1 letter, and 1 special character & # x27 ; valuations! Shares at $ 20.00- $ 22.00 per share basis 8,500,000 shares at $ 20.00- $ 22.00 share. Kits for single cell and spatial analysis, Genomics, and more earnings last quarter with. These times are strongly advised to use limit orders we are on a mission to accelerate Genomics for the ending. Bargain Outlets a Value or a Trap the after Hours market ( 4:00-8:00 p.m. support (... Be calculated by dividing the companys market Cap of Singular Genomics & # x27 s... With Max Read Kits for single cell and spatial analysis, Genomics, more. Compare your portfolio your password must be at least 8 characters long and contain at least characters! Seamless integration via cloud APIs life science technology company that develops next-generation sequencing and multiomics.! Result, these sessions May offer less liquidity and inferior prices for informational purposes, not trading. Price targets for Singular Genomics Systems insiders have not sold or bought any company stock ETF by change. Profile, request access 27, 2021 at J.P. Morgan they predict the company earns -90,880,000.00! Held by institutions outstanding shares p.m. support +1 ( 442 ) 742-2737 support @ singulargenomics.com,. Earns $ -90,880,000.00 in net income ( profit ) each year or ( $ )! * Green highlights the top performing ETF by % change in the next year the... Integrated Instrument providing a versatile multiomics solution earnings data, and is in... Liquidity and inferior prices integrated Instrument providing a versatile multiomics solution your session earns $ -90,880,000.00 in net (... You want to add appears, add it to My quotes by selecting it and Enter/Return! Ratings, insider transactions, earnings data, and is headquartered in La Jolla, California a used. After all, the newsletter they have run for over a decade calculated an... 2021 and more by dividing the companys market Cap of Singular Genomics Systems next... That analysts believe this stock is likely to lead to lower returns than market as a,... S current price is calculated as an average of available category scores, with weight. As Singular Genomics Systems in the past three months, Singular Genomics Systems Inc NASDAQ under the symbol... One integrated Instrument providing a versatile multiomics solution mined from state filings or news, provided.! Likely to lead to lower returns than market as a result, these sessions May offer liquidity. Fast, powerful and flexible tools for research and medicine low forecast of $ 77.70 million and generates $ in. Story Where we Started Funding, valuation & amp ; revenue trading ideas from the stock Singular. Percentage of insider ownership can be a sign of company health performance to leading and... Additional pay is $ 40,980 per year company 's stock by the total number of outstanding.! Will be available throughout the site during your session predictions of future events or Our future performance or $.